Publications & Endorsements

At Taryag Medical Ltd., the safety and well-being of patients is our top priority. Accordingly, All of our products undergo a rigorous clinical testing and validation process. Following are clinical studies pertaining to Taryag Medical products.

Percutaneous crossover rotational atherectomy recanalization: A case about health status and patency in a multimorbid vascular patient

August 28, 2024
Endovascular treatment of the common femoral artery (CFA) and its branches is often challenging. Sometimes, stent placement cannot be avoided. Furthermore, stent placement in this area carries several risks for complications. We present a challenging case in which we used a rotational atherectomy device percutaneously in cross-over-technique to recanalize the external iliac artery in combination with the femoral bifurcation, all in one session – and – without the need for a femoral stent in a multimorbid patient.
Learn more
PDF report of Percutaneous Crossover Rotational Atherectomy Recanalization

Safety and effectiveness of BYCROSS® rotational atherectomy and aspiration device: a prospective, multi-center pre-market approval study

March 29, 2023
From September 2018 until April 2019 39 patients with 41 femorodistal lesions including the femoropopliteal and distal popliteal segments were treated in a prospective, nonrandomized pre-market approval study with 6 months follow up using the ByCross® atherectomy device (ClinicalTrials.gov identifier NCT03724279).
Learn more